This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,157.37, is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC with the DLA is valued up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle for Amerisourcebergen to deliver specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs. These comprehensive contracting mechanisms enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Generated 2/27/25, 9:54 AM